EDCs and the European Union

We appreciate your interest in the subject of endocrine-disrupting chemicals (EDCs). More action is needed in the European Union (EU) mandate to ensure effective protection from harmful EDCs. Persistent regulatory gaps such as missing information requirements and very lengthy restriction processes under the EUs chemicals law, REACH, currently prevent the identification and control of many EDCs.

Annexes:

EDCs European Newsletter

To help share the latest science-based information on EDCs during the height of the pandemic, we prepared the following newsletters for policymakers in the EU. We urged policymakers to prioritize specific actions on EDCs, including a coherent identification process linked to control measures to reduce widespread exposures, and have seen a number of successes since then, including our inclusion in the UN’s International Negotiating Committee for the Plastics Treaty.  If you have any questions or requests for content, please reach out Joe Laakso, PhD, Director of Science Policy at [email protected].

Read our latest October 2025 Issue

 

 

Endocrine Disrupting Chemicals

EDCs EU Newsletter

Read our newsletters covering the latest science-based information on endocrine-disrupting chemicals (EDCs) for policymakers in the European Union.
Endocrine Disrupting Chemicals

EDCs EU Newsletter

Read our newsletters covering the latest science-based information on endocrine-disrupting chemicals (EDCs) for policymakers in the European Union.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.